pharma.markets

pharma.markets

  • HOME
  • Imprint

Vaccines

Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults

15/03/2022 MaP 0

Submission based on real-world safety and efficacy data from Israel Data showed rates of confirmed infections were 2 times lower and rates of severe illness […]

BioNTech – Statement on Humanitarian Aid in Ukraine

08/03/2022 MaP 0

Ugur Sahin, CEO and Co-Founder of BioNTech: “We at BioNTech are closely following the tragic situation in Ukraine and our thoughts are with everyone affected. […]

WHO Director-General’s opening remarks at announcement “spokes” of mRNA technology transfer hub

18/02/2022 MaP 0

Your Excellency President Macron,Excellency President Macky Sall,Excellency President Abdel Fattah Al-Sisi,Excellency President Kenyatta,Excellency President Buhari,Excellency President Saied,Excellency President Michel,Excellency President von der Leyen,Excellencies, dear colleagues, […]

BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa

16/02/2022 MaP 0

Developing turnkey solution to enable mRNA-based vaccine production in modular and scalable sites installed by BioNTech Presidents of Ghana, Rwanda, Senegal, the Director-General of the […]

Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request from U.S. FDA

01/02/2022 MaP 0

With pediatric COVID-19 cases surpassing 10 million and at the request of the FDA, the companies have submitted available data on the safety and efficacy […]

COVAX delivers its 1 billionth COVID-19 vaccine dose – with video

16/01/2022 MaP 0

On 15 January 2021, a shipment of 1.1 million COVID-19 vaccines to Rwanda included the billionth dose supplied via COVAX. Together with our partners, COVAX […]

WHO Interim statement on COVID-19 vaccines

11/01/2022 MaP 0

Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO Technical Advisory Group on COVID-19 Vaccine […]

BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential High-Risk SARS-CoV-2 Variants

11/01/2022 MaP 0

Early Warning System combines Spike protein structural modeling with artificial intelligence (AI) to detect and monitor high-risk SARS-CoV-2 variants, identifying >90% of WHO-designated variants on […]

Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA

06/01/2022 MaP 0

Merck has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO), for approximately USD 780 million in cash. Targeted […]

Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine

06/01/2022 MaP 0

Third mRNA vaccine collaboration between the companies aims to accelerate development of an improved vaccine for shingles, a debilitating, disfiguring and painful disease that affects […]

Spanish vaccine shows good results against omicron variant

05/01/2022 MaP 0

The future Spanish vaccine against covid, on which the Hipra laboratories based in Amer (Girona) are working, is showing good results against the omicron variant, […]

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older

03/01/2022 MaP 0

First emergency use authorization in the United States for a COVID-19 vaccine booster in adolescents 12 through 15 years of age Today’s FDA action also […]

Posts navigation

1 2 … 11 »

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Alzheimer
  • Animal health
  • Asthma
  • Bioscience
  • Cancer
  • Conferences
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • Food
  • HHS
  • Humanitarian Aid
  • Imprint
  • Influenza
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • Spain
  • Sports
  • Trade Fair
  • UN
  • Vaccines
  • Valencia Comunidad
  • WHO

Reports

  • European Stroke Organisation Conference 2022: New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery
  • UNICEF and WHO warn of ‘perfect storm’ of conditions for measles outbreaks, affecting children
  • Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System
  • Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
  • WHO issues new guidelines on abortion to help countries deliver lifesaving care

Archive

  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • European Stroke Organisation Conference 2022: New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery

    04/05/2022 0
  • UNICEF and WHO warn of ‘perfect storm’ of conditions for measles outbreaks, affecting children

    27/04/2022 0
  • Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System

    05/04/2022 0
  • Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults

    15/03/2022 0
  • WHO issues new guidelines on abortion to help countries deliver lifesaving care

    09/03/2022 0
Archives
  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid bayer biontech cancer commission companies coronavirus covid-19 covid19 data economy elpais.com emergency eu europe european fda food global guarantee health hygiene links medical merck novartis pandemic pfizer production recommendations region response roche safety scheme sector spain state statistics support vaccine vaccines who

Copyright © 2022 | WordPress Theme by MH Themes

Cookie Consent with Real Cookie Banner